CYTOTECH ApS: Financial statements 2018
CVR: 19898504
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
CYTOTECH ApS (CVR 19898504) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 265,895 and a net result of DKK 119,391 compared with DKK 48,552 the year before. That is a decrease of 1.3% compared with the year before. Equity in the 2018 report amounted to DKK 62,854. The solvency ratio was 25.4%.
- Gross Profit
- DKK 265,895
- Profit/Loss
- DKK 119,391
- Equity
- DKK 62,854
- Total Assets
- DKK 247,677
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 266 t. | 119 t. | 63 t. | - |
| 2017 | - | 270 t. | 49 t. | -57 t. | - |
| 2016 | - | 237 t. | -133 t. | -105 t. | - |
| 2015 | - | 354 t. | 13 t. | 27 t. | - |
| 2014 | - | 312 t. | -26 t. | 14 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
CYTOTECH ApS has published its annual report for 2017. Gross profit came to DKK 269,516, and the net result was DKK 48,552.
About CYTOTECH ApS
CYTOTECH ApS is a Danish company of the type Anpartsselskab based in Hellebæk, founded in 1997. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Patrick van Dijk Munch-Fals. The company is owned by Patrick van Dijk Munch-Fals. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 196,108 and a net result of DKK -70,656 compared with DKK -113,059 the year before. Equity in the 2025 report amounted to DKK -27,461.